AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)
AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)

Balance Sheet ACHN Quote Achillion P

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 20142015201620172018
CashAndCashEqui 74 82 77 43 50
ShortTermInvest 79 378 287 257 221
Cash 153 459 364 0 0
AccountReceivab 1 2 15 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 1 1 2 1 2
TotalCurrentAss 155 463 383 304 275
PPE 7 8 11 11 11
AccumulatedDepr -6 -6 -7 -8 -9
NetPPE 2 2 3 3 2
EquityAndOtherI 0 0 28 31 0
Goodwill 0 0 0 0 0
IntangibleAsset 0 0 0 0 0
OtherLTAssets 0 0 0 0 0
TotalNonCurrent 2 2 31 34 2
TotalAssets 157 465 414 338 278
ShortTermDebt 0 0 0 0 0
AccountsPayable 6 4 7 0 0
TaxesPayable 0 0 0 0 0
AccruedLiabilit 6 6 7 0 0
DeferredRevenue 0 0 0 0 0
OtherCurrentLia 1 4 0 4 4
TotalCurrentLia 13 15 14 13 12
Debt 0 0 0 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 0 0 0 0 0
TotalNonCurrent 0 0 0 0 0
TotalLiabilitie 13 15 14 13 12
CommonStock 0 0 0 0 0
AdditionalPaidI 600 905 917 927 939
RetainedEarning -451 -456 -517 -603 -673
AccumulatedOthe -6 0 0 0 0
TotalStockholde 143 450 399 325 266
TotalLiabilitie 157 465 414 338 278
Achillion Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Achillion Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.